Biomarkers

The study is part of broader research conducted at CCIPD to develop and apply novel AI

New imaging agent has been found to effectively predict treatment response of an up-and-coming cancer therapy

The method could also distinguish between patients with early versus later stages of OSCC

The CRISPR-based test uses a small blood sample and can deliver results within two hours

It is hoped that being able to diagnose the disease faster will also lead to the development of new treatment methods

While these biomarkers are promising, more research is still needed before they can be implemented

New study supports the notion that patients with type 2 diabetes should be divided into subgroups

An antibody predicts severe Crohn’s disease and is detectable up to seven years prior to disease diagnosis

Study discovers that "crown-like structures" surrounding breast tumors could hinder their response to therapy

Join Clinical Lab Manager and David Miklos, MD, PhD, to discuss recent advances in bispecific CAR-T therapy and biomarkers for characterizing CAR-T product quality.